September 2026
The global post-traumatic stress disorder treatment market size is projected to hit around USD 3.55 billion by 2035 from USD 2.47 billion in 2026, with a CAGR of 4.12%.
September 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 128.39 billion in 2026 with a CAGR of 6.07%.
April 2026
The global hyperpigmentation disorder treatment market size is estimated to hit around USD 12.28 billion by 2035 increasing from USD 6.19 billion in 2025, with a CAGR of 7.09%.
July 2025
The global autism spectrum disorder treatment market size was valued at USD 2.64 billion in 2026 and is expected to hit around USD 4.22 billion by 2034, at a CAGR of 6.03%.
September 2026
The global circadian rhythm sleep disorders market size was evaluated at USD 2.90 billion in 2026 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The global psychological distress market size was evaluated at USD 234.12 billion in 2026 and is predicted to hit around USD 490.71 billion by 2035, growing at a CAGR of 8.57%.
September 2026
The autoimmune neurological disorders market generated USD 9.17 billion in 2026, with prominent autoimmune neurological disorders market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The global diabetic foot ulcer treatment market size is projected to hit around USD 17.06 billion by 2035 from USD 10.24 billion in 2026 with a CAGR of 5.84%.
September 2026
The global esophageal atresia treatment market size was evaluated at USD 314.58 billion in 2026 and is predicted to hit around USD 578.34 billion by 2035, growing at a CAGR of 7.00%.
September 2026
The global keloid treatment market size was evaluated at USD 4.28 billion in 2026 and is predicted to hit around USD 6.10 billion by 2035, growing at a CAGR of 4.00%.
September 2026
The global gastrointestinal bleeding treatment market size was evaluated at USD 350.47 million in 2026 and is predicted to hit around USD 889.26 million by 2035, growing at a CAGR of 10.90%.
September 2026
The global herpes treatment market size was evaluated at USD 1.66 billion in 2026 and is predicted to hit around USD 3.92 billion by 2035, growing at a CAGR of 10.00%.
September 2026
The global psoriasis treatment market size is expected to increase from USD 36.87 billion in 2026 and is projected to hit around USD 73.04 billion by 2035, with a CAGR of 7.9%.
September 2026
The global non-invasive aesthetic treatment market is evaluated at USD 24.45 billion in 2026 and is predicted to hit around USD 43.75 billion by 2035, at a CAGR of 6.8%.
September 2026
The asthma treatment market size accounted for USD 29.56 billion in 2026 and is expected to hit around USD 36.8 billion by 2035, poised to grow at a CAGR of 2.42%.
September 2026
The global acne treatment market size was valued at USD 12.86 billion in 2026 and is expected to hit around USD 20.99 billion by 2035, growing at a CAGR of 5.60%.
September 2026
The wastewater treatment chemicals market size is valued at USD 40.32 billion in 2026 and is expected to hit around USD 56.76 billion by 2035 with a CAGR of 3.87%.
September 2026
The global stomach cancer treatment market size is estimated to surpass around USD 19.42 billion by 2035 from USD 6.84 billion in 2026, with a solid CAGR of 12.31%.
September 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 3.05 billion in 2026, at a solid CAGR of 6.00%.
September 2026
The global dental fluoride treatment market size is valued at USD 19.97 billion in 2026 and is projected to hit around USD 44.06 billion by 2034 with a CAGR of 10.40%.
September 2026
The global postmenopausal osteoporosis treatment market size is calculated at USD 14.20 billion in 2026 and is projected to hit around USD 22.51 billion by 2035 with a CAGR of 5.26%.
September 2026
The global liver fibrosis treatment market size is estimated to hit around USD 57.11 billion by 2035 from USD 22.60 billion in 2026, with a solid CAGR of 10.87%.
September 2026
The global rosacea treatment market size is estimated at USD 2.43 billion in 2026 and is projected to surpass around USD 4.23 billion by 2034, with a solid CAGR of 7.14%.
September 2026
The global radiation treatment planning solutions market size was evaluated at USD 3.23 billion in 2026 and is predicted to hit around USD 6.53 billion by 2035, growing at a CAGR of 8.15%.
September 2026
The global varicose veins treatment market size was evaluated at USD 1.69 billion in 2026 and is predicted to hit around USD 2.96 billion by 2035, growing at a CAGR of 6.44%.
September 2026
The global intensive anti-aging treatment market size was evaluated at USD 32.07 billion in 2026 and is predicted to hit around USD 61.24 billion by 2035, growing at a CAGR of 7.45%.
September 2026
The global middle ear infections treatment market size is estimated to hit around USD 8.44 billion by 2035 increasing from USD 5.66 billion in 2026, with a CAGR of 4.55%.
September 2026
The tendonitis treatment market size was calculated at USD 249.63 billion in 2026 and is projected to hit around USD 340.22 billion by 2035 with a CAGR of 3.50%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com